GPFT.US Grapefruit USA Inc

Healthcare Pharmaceuticals USA Stocks
0.0002 USD
Close of Nov 10, 2026
0.0001 0.0012
Market cap
USD 232K
P/E
-
P/B
14.37x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is GPFT.US undervalued?

Graham number

The Graham number of Grapefruit USA Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Grapefruit USA Inc fundamental analysis

No fundamental analysis for Grapefruit USA Inc yet.

Grapefruit USA Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Grapefruit USA Inc

Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. Grapefruit USA, Inc. was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was incorporated in 2017 and is based in Los Angeles, California.

Full company profile